Investors - Press Releases
|View printer-friendly version|
BayCare Health System to Present on Improved Pharmacy Operations Using DoseMeRx and Cerner Electronic Health Record at Cerner Health Conference 2019
"The impact of DoseMeRx integrated within the EHR has been eye-opening,” said
The interactive session will be led by
“The new draft consensus vancomycin guidelines suggest the preferred approach to monitor AUC involves the use of Bayesian dosing decision-support programs, such as DoseMeRx. For our team, it’s critical that decision support is integrated into our workflow in the EHR to ensure widespread and regular clinical usage,” said Walton, “The Cerner Health Conference is a perfect opportunity to demonstrate how we deployed DoseMeRx within the Cerner EHR and optimized vancomycin dosing for thousands of patients in just a couple of months.”
DoseMe team will demonstrate how easily DoseMeRx optimizes the dosing of vancomycin and much more in the Cerner ERH at booth 322 at the Conference.
DoseMe is a
BayCare offers a wide range of programs and services to meet the health care needs of individuals and communities throughout
This press release includes forward-looking statements that we believe to be reasonable as of today’s date, including statements regarding Medication Risk Mitigation technology. Such statements are identified by use of the words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “projects,” “should,” and similar expressions. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release. Actual results might differ materially from those explicit or implicit in the forward-looking statements. Important factors that could cause actual results to differ materially include: the need to innovate and provide useful products and services; risks related to changing healthcare and other applicable regulations; increasing consolidation in the healthcare industry; managing our growth effectively; our ability to adequately protect our intellectual property; and the other risk factors set forth from time to time in our filings with the SEC, including those factors discussed under the caption “Risk Factors” in our most recent annual report on Form 10-K, filed with the
|Media Contact |
T: (215) 870-0829
Bob East or Asher Dewhurst
T: (443) 213-0500
Source: Tabula Rasa HealthCare, Inc.